Characterization of efflux transport of organic anions in a mouse brain capillary endothelial cell line

Journal of Pharmacology and Experimental Therapeutics

Volumn 285, Issue 3, 1998, Pages 1260-1265

  Kusuhara, Hiroyuki ^a   Suzuki, Hiroshi ^a   Naito, Mikihiko ^a   Tsuruo, Takashi ^a   Sugiyama, Yuichi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE DERIVATIVE; LEUKOTRIENE C4;

ANIMAL CELL; ANION TRANSPORT; ARTICLE; BLOOD BRAIN BARRIER; BRAIN CAPILLARY; CAPILLARY ENDOTHELIUM; CONTROLLED STUDY; ENDOTHELIUM CELL; IMMUNOBLOTTING; MEMBRANE VESICLE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ANIONS; BLOTTING, NORTHERN; BLOTTING, WESTERN; BRAIN; CAPILLARIES; CELL MEMBRANE; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; GLUTATHIONE; ION TRANSPORT; LEUKOTRIENE C4; MALE; MICE; RATS; RATS, WISTAR; SUCROSE;

EID: 0031809205     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Ballatori N and Truong AT (1995) Multiple canalicular transport mechanisms for glutathione S-conjugates. Transport on both ATP- and voltage-dependent carriers. J Biol Chem 270:3594-3601.
2. Böhme M, Müller M, Leier I, Jedlitschky G and Keppler D (1994) Cholestasis caused by inhibition of the adenosine triphosphate-dependent bile salt transport in rat liver. Gastroenterology 107:255-265.
3. Bradbury MW (1979) The Concept of a Blood-Brain Barrier. Wiley, Chichester, 1979
4. Cornford EM, Diep CP and Pardridge WM (1985) Blood-brain barrier transport of valproic acid. J Neurochem 44:1541-1550.
5. Croop JM, Raymond M, Hber D, Devault A, Arceci RJ, Gros P and Housman DE (1989) The three mouse multidrug resistance (mdr) genes are expressed in a tissue-specific manner in normal mouse tissues. Mol Cell Biol 9:1346-1350.
6. Flens MJ, Zaman GJ, van der Valk P, Izquierdo MA, Schroeijers AB, Scheffer GL, van der Groep P, de Haas M, Meijer CJ and Scheper RJ (1996) Tissue distribution of the multidrug resistance protein. Am J Pathol 148:1237-1247.
7. 4 by membrane vesicles prepared from cisplatin-resistant human epidermoid. J Natl Cancer Inst 86:1781-1784.
8. Ghersi-Egea JF, Leininger B, Suleman G and Minn A (1994) Localization of drug-metabolizing enzyme activities to blood-brain interfaces and circumventricular organs. J Neurochem 62:1089-1096.
9. Ishikawa T, Müller M, Klunemann C, Schaub T and Keppler D (1990) ATP-dependent primary active transport of cysteinyl leukotrienes across liver canalicular membrane. Role of the ATP-dependent transport system. J Biol Chem 265: 19279-19286.
10. Ishikawa, T (1992) The ATP-dependent glutathione S-conjugate export pump. Trends Biochem Sci 17:463-468.
11. Ito K, Suzuki H, Hirohashi T, Kume K, Shimizu T and Sugiyama Y (1996) Expression of the putative ATP-binding cassette region homologous to that in multidrug resistance associated protein (MRP), is hereditarily defective in Eisai hyperbirilubinemic rats (EHBR). Int Hepatol Commun 4:292-299.
12. Ito K, Suzuki H, Hirohashi T, Kume K, Shimizu T and Sugiyama Y (1997) Molecular cloning of canalicular multispecific organic anion transporter defective in EHBR. Am J Physiol 272:G16-G22.
13. Ito K, Suzuki H, Hirohashi T, Kume K, Shimizu T and Sugiyama Y (1998) Functional analysis of a canalicular multispecific organic anion transporter cloned from rat liver. J Biol Chem 273:1684-1688.
14. Jedlitschky G, Leier I, Buchholz U, Barnouin K, Kurz G and Keppler D (1996) Transport of glutathione, glucuronate, and sulfate conjugates by the MRP gene-encoded conjugate export pump. Cancer Res 56:988-994.
15. Keppler D and Arias IM (1997) Hepatic canalicular membrane. Introduction: transport across the hepatocyte canalicular membrane. FASEB J 11:15-18.
16. Kobayashi K, Sogame Y, Hara H and Hayashi K (1990) Mechanism of glutathione S-conjugate transport in canalicular and basolateral rat liver plasma membranes. J Biol Chem 265:7737-7741.
17. Kusuhara H, Suzuki H and Sugiyama Y (1997) The role of P-glycoprotein and canalicular multispecific organic anion transporter (cMOAT) in the hepatobiliary excretion of drugs. J Pharm Sci, in press.
18. Lautier D, Canitrot Y, Deeley RG and Cole SPC (1996) Multidrug resistance mediated by the multidrug resistance associated protein (MRP) gene. Biochem Pharmacol 52:967-977.
19. Leininger B, Ghersi-Egea JF, Siest G and Minn A (1991) In vivo study of the elimination from rat brain of an intracerebrally formed xenobiotic metabolite, 1-naphthyl-β-D-glucuronide. J Neurochem 56:1163-1168.
20. 4 export carrier in mastocytoma cells. Eur J Biochem 220:599-606.
21. Loe DW, Deeley RG and Cole SPC (1996a) Biology of the multidrug resistance associated protein, MRP. Eur J Cancer 32:945-957.
22. 4 and chemotherapeutic agents in membrane vesicles. J Biol Chem 271:9675-9682.
23. Masereeuw R, Jaehde U, Langemeijer MW, de Boer AG and Breimer DD (1994) In vitro and in vivo transport of zidovudine (AZT) across the blood-brain barrier and the effect of transport inhibitors. Pharm Res 11:324-330.
24. Matsushita H, Suzuki H, Sugiyama Y, Sawada Y, Iga T, Kawaguchi T and Hanano M (1991) Facilitated transport of cefodizime into the rat central nervous system. J Pharmacol Exp Ther 259:620-625.
25. Oude-Elferink RPJ, Meijer DKF, Kuipers F, Jansen PLM, Groen AK and Groothuis GMM (1995) Hepatobiliary secretion of organic compounds, molecular mechanisms of membrane transport. Biochim Biophys Acta 1241:215-268.
26. Pardridge WM, Eisenerg J and Yamada T (1985) Rapid sequestration and degradation of somatostatin analogues by isolated brain microvessels. J Neurochem 44: 1178-1184.
27. Pardridge WM (1991) Peptide Drug Delivery to the Brain. Raven, New York, 1991.
28. Rapoport SI (1976) Blood-Brain Barrier in Physiology and Medicine. Raven, New York, 1976.
29. Sathirakul K, Suzuki H, Yasuda K, Hanano M and Sugiyama Y (1994) Multiple transport systems for organic anions across the bile canalicular membrane. J Pharmacol Exp Ther 268:65-73.
30. Saxena M and Henderson GB (1995) ATP-dependent efflux of 2,4-dinitrophenyl-S-glutathione. J Biol Chem 270:5312-5319.
31. Schinkel AH, Smit JJM, van Tellingen O, Beijnen JH, Wagenaar E, van Deemter L, Mol CAAM, van der Valk MA, Robanus-Mandaag EC, te Riele HPJ, Berns AJM and Borst P (1994) Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell 77:491-502.
32. Stride BD, Valdimarsson G, Gerlach JH, Wilson GM, Cole SPC and Deeley RG (1996) Structure and expression of the messenger RNA encoding the murine multidrug resistance protein, an ATP-binding cassette transporter. Mol. Pharmacol. 49:962-971.
33. Stride BD, Grant CE, Loe DW, Hipfer DR, Cole SPC and Deeley RG (1997) Pharmacological characterization of the murine and human multidrug resistance proteins (MRP) in human embryonic kidney. Mol Pharmacol 52:344-353.
34. Suzuki H, Terasaki T and Sugiyama Y (1997) Role of efflux transport across the blood-brain barrier and blood-cerebrospinal fluid barrier on the disposition of xenobiotics in the central nervous system. Adv Drug Deliv Rev 25:257-285.
35. Takasawa K, Terasaki T, Suzuki H and Sugiyama Y (1997) In vivo evidence for carrier mediated efflux transport of 3′-azide-3′-deoxythymidine and 2′,3′-dideoxyinosine across the blood-brain barrier via probenecid sensitive transport system. J Pharmacol Exp Ther 281:369-375.
36. Tatsuta T, Naito M, Oh-Hara T, Sugawara I and Tsuruo T (1992) Functional involvement of P-glycoprotein in blood-brain barrier. J Biol Chem 267:20383-20391.
37. Tamai I and Tsuji A (1996) Drug delivery through the blood brain barrier. Adv Drug Deliv Rev 19:401-424.
38. Wijnholds J, Evers R, vanLeusden MR, Mol CAAM, Zaman GJR, Mayer U, Beijnen JH, vanderValk M, Krimpenfort P and Borst P (1997) Increased sensitivity to anticancer drugs and decreased inflammatory response in mice lacking the multidrug resistance-associated protein. Nature Med 3:1275-1279.
39. Yamaoka K, Tanigawara T, Nakagawa T and Uno T (1981) A Pharmacokinetic analysis program (MULTI) for microcomputer. J Pharmacobio-dyn 4:879-885.
40. Yamazaki M, Suzuki H and Sugiyama Y (1993) Recent advances in carrier-mediated hepatic uptake and biliary excretion of xenobiotics. Pharm Res 13:497-513.